Oncology
2 drugs are in development for Lymphoma.
- Companies
- 2
- Clinical trials
- 67
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Lymphoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| eb103 | Estrella Immunopharma Inc. (ESLA) |
About this indication
Lymphoma context
Oncology·MeSH: Lymphoma (D008223)
Also known as: Germinoblastic Sarcoma, Germinoblastic Sarcomas, Germinoblastoma, Germinoblastomas, Lymphomas, Lymphomas, Malignant, Malignant Lymphoma, Reticulolymphosarcoma, Reticulolymphosarcomas
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Lymphoma?
BioSniper tracks 2 drugs in development for Lymphoma across 2 companies.
How many clinical trials target Lymphoma?
There are 67 clinical trials targeting Lymphoma tracked by BioSniper.
What is the prevalence of Lymphoma?
The estimated prevalence of Lymphoma is approximately 56.0 per 100,000 population.